|
|
Study on the mechanism of the main drugs of Heidou Formula in the treatment of eczema based on network pharmacology |
QU Yao1 FAN Yu2 LIU Lüye3 WANG Yujing3 ZHANG Jie1 GENG Lidong2 |
1.The First Clinical Medical School, Shandong University of Traditional Chinese Medicine, Shandong Province, Ji’nan 250014, China;
2.Department of Dermatology, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shandong Province, Ji’nan 250014, China;
3.College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Shandong Province, Ji’nan 250014, China |
|
|
Abstract Objective To study the mechanism of the main drugs of Heidou Formula in the treatment of eczema. Methods Drug components, corresponding targets and disease-related genes were obtained through relevant online databases (traditional Chinese medicine systems pharmacology database and analysis platform, DrugBank, GeneCards, on-line Mendelian inheritance in man database). Network relationship was constructed by software and analysis of related bioinformatics was conducted to explore the mechanism of the main drugs of Heidou Formula (Sojae Semen Nigrum, Portulacae Herba, Lycii Cortex, Phellodendri Chinensis Cortex, Dictamni Cortex, Bletillae Rhizoma) in the treatment of eczema. Results Six drugs with 89 ingredients and 47 drug-eczema intersection genes were selected from the databases. A network analysis of the data indicated that quercetin, stigmasterol and other components might be the main therapeutic components for eczema. Network analysis showed that the therapeutic process of Heidou Formula for eczema might be closely related to genes, such as interleukin 6, caspase 3, human recombinant protein P01 and tumor necrosis factor signaling pathway. Conclusion Heidou Formula for eczema is the result of the interaction of multiple drug components through multiple targets and pathways, which provides a theoretical basis for the clinical application of Heidou Formula for the treatment of eczema. It reveals some of the key genes and pathways in the treatment of eczema that has not yet been defined, and provides a reference for the subsequent drug application and clinical treatment.
|
|
|
|
|
[1] 杨志波.湿疹中医临床诊疗指南的开发[C]//中国中西医结合学会疡科分会,天津市中医药研究院,中国中西医结合学会.第十三次全国中西医结合疡科学术交流会论文汇编,2007:60-61.
[2] 解晶,李丰,石彬彬,等.系统药理学:TCMSP解析中医基础理论研究进展[J].世界中医药,2019,14(10):2627-2635.
[3] Ru J,Li P,Wang J,et al. TCMSP:a data base of systems pharmacology for drug discovery from herbal medicines [J]. J Cheminform,2014,6:13.
[4] 罗静初.UniProt蛋白质数据库简介[J].生物信息学,2019, 17(3):131-144.
[5] 张功,于莹,黄海量,等.基于网络药理学和生物信息学探讨四神丸治疗溃疡性结肠炎的作用机制[J].中国实验方剂学杂志,2019,25(24):142-149.
[6] 史佩玉,林樫,陈国铭,等.基于网络药理学的葶苈子潜在作用机制研究[J].中国药房,2019,30(20):2823-2828.
[7] Piao CL,Luo JL,Jin D,et al. Utilizing network pharmacology to explore the underlying mechanism of Radix Salviae in diabetic retinopathy [J]. Chin Med,2019,14:58.
[8] Yang X,Li Y,Lv R,et al. Study on the Multitarget Mechanism and Key Active Ingredients of Herba Siegesbeckiae and Volatile Oil against Rheumatoid Arthritis Based on Network Pharmacology [J]. Evid Based Complement Alternat Med,2019:8957245.
[9] Kramarz B,Roncaglia P,Meldal B,et al. Improving the Gene Ontology Resource to Facilitate More Informative Analysis and Interpretation of Alzheimer’s Disease Data [J]. Genes(Basel),2018,9(12):593.
[10] 万大群,赵仁全,刘海,等.白及的成分、药理作用和临床应用研究进展[J].中国药业,2017,26(2):93-96.
[11] 周晓鹰,陈洁,金柳,等.白鲜皮的药理作用及抗炎活性成分研究进展[J].常州大学学报:自然科学版,2018,30(1):82-86.
[12] 陈辉,曹兵,朱莹,等.地骨皮化学成分研究[J].中草药,2019,50(6):1299-1304.
[13] 姚欢欢,陈吉,陈思思,等.基于AMPK/GLUT4/GSK3β/PPARα信号通路研究地骨皮水提物改善2型糖尿病大鼠胰岛素抵抗的实验研究[J].中国医药导报,2020, 17(5):8-12,198.
[14] 陈阳峰,钟晓红.黄柏的药理作用及其活性成分提取[J].作物研究,2015,29(5):564-568.
[15] 王天宁,刘玉婷,肖凤琴,等.马齿苋化学成分及药理活性的现代研究整理[J].中国实验方剂学杂志,2018,24(6):224-234.
[16] 刘秀玉,王利丽,左瑞庭,等.药用黑豆的研究进展[J].亚太传统医药,2017,13(20):82-85.
[17] 陈红君,干志彬,刘霞,等.黄酮类成分黄芩素、槲皮素、丹参素钠对吸烟致细胞毒性和DNA损伤的保护作用[J].现代药物与临床,2014,29(1):21-26.
[18] 刘志强,王博龙.中药网络药理学研究:蛋白互作网络构建与功能注释[J].湖北民族学院学报:医学版,2018, 35(3):49-52.
[19] 陈国铭,钟晓莹,赵金龙,等.黄芪桂枝五物汤治疗糖尿病周围神经病变靶点预测与机制探讨[J].中国实验方剂学杂志,2018,24(8):214-222.
[20] 冯莉芳,张玲莉.槲皮素对脂多糖诱导人肝细胞炎性损伤的改善作用及其机制[J].广西医学,2019,41(1):71-75.
[21] 徐海瑛,郝红英,陈青阁,等.鱼腥草活性成分槲皮素及其金属配合物的抗菌活性[J].江苏农业科学,2018,46(21):218-220.
[22] 陈仲巍,曾臻,杨丙晔,等.槲皮素在鼻咽癌细胞中的抗肿瘤活性研究[J].海峡药学,2018,30(7):23-25.
[23] 张林,欧祥琴,张涛,等.基于加权基因共表达网络分析槲皮素抗胃癌的基因模块和分子标记物研究[J/OL].世界中医药.[2021-02-20].http://kns.cnki.net/kcms/detail/11.5529.R.20210111.1331.002.html.
[24] 周枝,刘畅,俸婷婷,等.黄褐毛忍冬对大鼠急性肺损伤模型的抗炎机制研究[J].中国中药杂志,2020,45(20):4978-4983.
[25] 张玲,林素财,郑永平.肤悦康洗剂对湿疹豚鼠的治疗作用及其免疫调节机制[J].西部中医药,2020,33(9):23-26.
[26] 彭艳梅.中医药治疗EGFRIs相关皮肤不良反应的临床和实验研究[D].北京:北京中医药大学,2019.
[27] Boezio B,Audouze K,Ducrot P,et al. Network-based Approaches in Pharmacology [J]. Mol Inform,2017,36(10):1700048. |
|
|
|